Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCN-032 in Healthy Volunteers Challenged with Influenza A
NCT01719874Phase 2Unknown
- Sponsor
- Theraclone Sciences
- Start
- Aug 2012
- Primary completion
- Dec 2012
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Influenza A (IAV) comparing TCN-032 with Placebo (2 arms). Primary endpoint: Development of clinical signs and symptoms of influenza at 7 days. Status: unknown.
02
Drugs
TCN-032
03
Conditions
Influenza A (IAV)
Beyond the preview
Go deeper on NCT01719874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01719874.